Hudson Value Partners LLC Invests $212,000 in Colgate-Palmolive (NYSE:CL)

Hudson Value Partners LLC acquired a new position in Colgate-Palmolive (NYSE:CL) during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 2,040 shares of the company’s stock, valued at approximately $212,000.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the business. Principal Financial Group Inc. boosted its stake in shares of Colgate-Palmolive by 4.9% during the 3rd quarter. Principal Financial Group Inc. now owns 997,147 shares of the company’s stock worth $103,514,000 after acquiring an additional 46,944 shares in the last quarter. Montecito Bank & Trust grew its holdings in Colgate-Palmolive by 75.2% during the third quarter. Montecito Bank & Trust now owns 11,302 shares of the company’s stock valued at $1,173,000 after purchasing an additional 4,851 shares during the last quarter. BNC Wealth Management LLC bought a new position in shares of Colgate-Palmolive in the third quarter valued at approximately $2,053,000. Graypoint LLC boosted its holdings in shares of Colgate-Palmolive by 3.7% during the 3rd quarter. Graypoint LLC now owns 6,007 shares of the company’s stock worth $624,000 after buying an additional 214 shares during the period. Finally, Forte Capital LLC ADV grew its stake in Colgate-Palmolive by 2.5% in the 3rd quarter. Forte Capital LLC ADV now owns 18,506 shares of the company’s stock valued at $1,921,000 after buying an additional 460 shares during the last quarter. Institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Stock Up 0.6 %

Shares of CL opened at $90.77 on Friday. The business’s fifty day moving average price is $101.49 and its two-hundred day moving average price is $98.39. The firm has a market capitalization of $74.16 billion, a price-to-earnings ratio of 26.01, a PEG ratio of 3.34 and a beta of 0.42. Colgate-Palmolive has a 52 week low of $74.67 and a 52 week high of $109.30. The company has a debt-to-equity ratio of 9.46, a quick ratio of 0.68 and a current ratio of 1.04.

Colgate-Palmolive Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Friday, October 18th will be paid a $0.50 dividend. The ex-dividend date of this dividend is Friday, October 18th. This represents a $2.00 dividend on an annualized basis and a yield of 2.20%. Colgate-Palmolive’s payout ratio is presently 57.31%.

Insider Buying and Selling

In other Colgate-Palmolive news, Director Martina Hundmejean sold 2,313 shares of the stock in a transaction on Friday, August 23rd. The shares were sold at an average price of $103.86, for a total value of $240,228.18. Following the sale, the director now directly owns 11,755 shares in the company, valued at approximately $1,220,874.30. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. In related news, CFO Stanley J. Sutula III sold 45,410 shares of the stock in a transaction on Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the completion of the transaction, the chief financial officer now owns 36,726 shares in the company, valued at approximately $3,456,283.86. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Martina Hundmejean sold 2,313 shares of the business’s stock in a transaction dated Friday, August 23rd. The stock was sold at an average price of $103.86, for a total transaction of $240,228.18. Following the sale, the director now directly owns 11,755 shares in the company, valued at $1,220,874.30. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.37% of the stock is owned by insiders.

Wall Street Analyst Weigh In

Several equities research analysts have recently issued reports on the company. HSBC reaffirmed a “hold” rating on shares of Colgate-Palmolive in a research report on Friday, July 26th. Wells Fargo & Company cut their price target on Colgate-Palmolive from $100.00 to $92.00 and set an “underweight” rating for the company in a report on Monday, October 28th. TD Cowen decreased their price objective on Colgate-Palmolive from $115.00 to $110.00 and set a “buy” rating on the stock in a report on Monday, October 28th. Barclays raised their target price on Colgate-Palmolive from $91.00 to $96.00 and gave the stock an “equal weight” rating in a research report on Monday, July 29th. Finally, StockNews.com upgraded shares of Colgate-Palmolive from a “hold” rating to a “buy” rating in a research note on Wednesday. One equities research analyst has rated the stock with a sell rating, nine have assigned a hold rating and thirteen have issued a buy rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $105.11.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.